Ignite Creation Date:
2024-05-05 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00436371
Status:
COMPLETED
Last Update Posted:
2008-09-05
First Post:
2007-02-15
Brief Title:
Amisulpride in Schizophrenic Acute Phase Patients
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
The Use of Amisulpride in Schizophrenic Acute Phase Patients
Status:
COMPLETED
Status Verified Date:
2008-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ASAP
Brief Summary:
To collect the safety and response of using Amisulpride in acute schizophrenic patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None